FDA Warning Letters for Misbranding Cannabinoid Products as Dietary Supplement on the Rise – Bella Rose Labs

FDA issues warning letter to New York manufacturer for CBD claims that indicates its products are new drugs and do not qualify as dietary supplements

Federal District Court Orders New York Company to Stop Distributing Adulterated and Misbranded Dietary Supplements

FDA enforcement warning letters sent to manufacturers of CBD based dietary supplements due to non-permissible misbranding and adulteration claims